Aindri (Centella asiatica)

Aindri (Centella asiatica) is an Ayurvedic herb containing triterpenoid saponins like asiaticoside and madecassoside as primary bioactive compounds. These compounds may modulate collagen synthesis and inflammatory pathways, though human clinical evidence remains limited.

Origin & History

Aindri (Centella asiatica) is a perennial herb native to tropical regions of Asia, Africa, Australia, and the Pacific Islands, commonly known as gotu kola or Indian pennywort. The aerial parts (leaves and stems) are harvested and processed using various extraction methods including water, ethanol, or advanced ionic liquid techniques to concentrate key triterpene saponins like asiaticoside and madecassoside.

Historical & Cultural Context

While the research mentions Centella asiatica is categorized under Ayurveda where it's known as Aindri, no specific historical context, traditional indications, or duration of use are detailed in the provided sources.

Health Benefits

• No clinical health benefits can be reported - the research dossier lacks human clinical trials or RCTs
• The research focuses only on extraction methods rather than therapeutic outcomes
• Traditional use suggests potential benefits but no evidence quality can be assigned
• Active compounds (asiaticoside, madecassoside) have been identified but not clinically tested
• Further clinical research is needed to establish evidence-based health claims

How It Works

Asiaticoside and madecassoside in Aindri may stimulate collagen synthesis through enhanced fibroblast proliferation and increased collagen gene expression. These triterpenoid saponins potentially modulate inflammatory responses by inhibiting NF-κB signaling pathways and reducing pro-inflammatory cytokine production.

Scientific Research

The research dossier contains no human clinical trials, RCTs, or meta-analyses for Centella asiatica. All provided sources focus on extraction methodologies and compound identification rather than clinical efficacy or therapeutic outcomes.

Clinical Summary

Current research on Aindri focuses primarily on extraction methods and compound identification rather than therapeutic outcomes. No high-quality randomized controlled trials in humans have been conducted to validate traditional uses. Available studies are limited to in vitro and animal models, preventing reliable conclusions about clinical efficacy. The evidence quality for human health benefits remains insufficient for definitive therapeutic recommendations.

Nutritional Profile

Centella asiatica (Aindri) contains a distinct profile of bioactive triterpenoid saponins as its primary constituents, with limited macronutrient significance as it is consumed in medicinal rather than dietary quantities. Key bioactive compounds include: asiaticoside (0.1–8% dry weight), madecassoside (0.3–2.7% dry weight), asiatic acid (0.5–1.5% dry weight), and madecassic acid (0.3–1.0% dry weight). These four pentacyclic triterpenoids collectively referred to as 'total triterpenic fraction of Centella asiatica (TTFCA)' constitute the pharmacologically active core. Flavonoids present include quercetin, kaempferol, and rutin at trace concentrations (approximately 0.1–0.5% dry weight). Polyacetylene compounds (centellin, centellicin) are identified in minor quantities. The herb contains essential oils (0.1% approximately) including beta-caryophyllene, farnesol, and elemicine. Mineral content includes calcium (~171 mg/100g fresh leaf), potassium (~391 mg/100g), iron (~3.1 mg/100g), and magnesium (~18 mg/100g) based on fresh leaf analysis. Vitamin content includes vitamin C (~48 mg/100g fresh weight), vitamin A precursors (beta-carotene ~6.9 mg/100g), and vitamin B2 (riboflavin ~0.19 mg/100g). Crude fiber constitutes approximately 2.3g/100g fresh weight; protein approximately 2.8g/100g fresh weight; carbohydrates approximately 6.0g/100g fresh weight. Bioavailability note: asiaticoside undergoes hydrolysis in the gut to release asiatic acid, which is the primary absorbed form; lipid-based delivery formulations have been shown in in vitro studies to enhance triterpenoid absorption compared to aqueous extracts. Chlorogenic acid and caffeic acid derivatives are present as minor phenolic contributors.

Preparation & Dosage

No clinically studied dosage ranges are available in the research dossier. The sources focus on extraction processes without providing therapeutic dosing data or standardization details. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient data - no synergistic ingredients identified in research

Safety & Interactions

Safety data for Aindri supplementation in humans is limited due to lack of clinical trials. Traditional use suggests general tolerability, but potential side effects, optimal dosing, and drug interactions remain undefined. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals taking medications should consult healthcare providers before use given unknown interaction potential.